The fastest-growing and largest of the 20 sized Pharmaceuticals markets in APAC, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Biosimilars | $7.7 Bn | $79.2 Bn | 26.2% | 60 |
| 2 | Cell Based Immunotherapy | $3.5 Bn | $30.6 Bn | 24.3% | 6,743 |
| 3 | Cannabidiol (CBD) | $4.6 Bn | $24.4 Bn | 18.1% | 20 |
| 4 | Cannabis | $7.1 Bn | $28.2 Bn | 14.8% | 20 |
| 5 | Atopic Dermatitis Drugs | $2.4 Bn | $8.3 Bn | 13.5% | 110 |
| 6 | Oncology/Cancer Drugs | $37.2 Bn | $93.6 Bn | 9.7% | 8,800 |
| 7 | Anti-Aging | $18.5 Bn | $45.4 Bn | 9.4% | 262 |
| 8 | Diabetes Management | $16.4 Bn | $36.6 Bn | 8.4% | 608 |
| 9 | Alzheimer Drugs | $441 Mn | $967 Mn | 8.2% | 211 |
| 10 | Contraceptives Drugs | $5.3 Bn | $11.5 Bn | 8.1% | 7 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Oncology/Cancer Drugs | $37.2 Bn | $93.6 Bn | 9.7% | 8,800 |
| 2 | Anti-Aging | $18.5 Bn | $45.4 Bn | 9.4% | 262 |
| 3 | Diabetes Management | $16.4 Bn | $36.6 Bn | 8.4% | 608 |
| 4 | Gastrointestinal Drugs | $11.3 Bn | $20.1 Bn | 5.9% | 3,122 |
| 5 | Asthma & COPD Drugs | $10.4 Bn | $17.4 Bn | 5.3% | 248 |
| 6 | Biosimilars | $7.7 Bn | $79.2 Bn | 26.2% | 60 |
| 7 | Cannabis | $7.1 Bn | $28.2 Bn | 14.8% | 20 |
| 8 | HIV Drugs | $6.3 Bn | $12.5 Bn | 7.1% | 102 |
| 9 | Contraceptives Drugs | $5.3 Bn | $11.5 Bn | 8.1% | 7 |
| 10 | Cancer Supportive Care Drugs | $5.2 Bn | $9.3 Bn | 6% | 716 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running, in China, India, Japan, Australia, Hong Kong, Philippines, Singapore, Thailand, Malaysia, New Zealand.
Biosimilars grows fastest, at 26.2% a year from 2023 to 2033, ahead of Cell Based Immunotherapy (24.3%).
Oncology/Cancer Drugs is the largest, worth about $37.2 Bn in 2023 and $93.6 Bn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.